$107.09
0.82% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US5255582018
Symbol
LMAT

LeMaitre Vascular, Inc. Stock price

$107.09
+21.45 25.05% 1M
+27.34 34.28% 6M
+50.33 88.67% YTD
+53.74 100.73% 1Y
+56.21 110.48% 3Y
+71.14 197.89% 5Y
+99.82 1,373.04% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.88 0.82%
ISIN
US5255582018
Symbol
LMAT
Sector

Key metrics

Market capitalization $2.41b
Enterprise Value $2.30b
P/E (TTM) P/E ratio 58.74
EV/FCF (TTM) EV/FCF 68.74
EV/Sales (TTM) EV/Sales 10.81
P/S ratio (TTM) P/S ratio 11.30
P/B ratio (TTM) P/B ratio 7.27
Dividend yield 0.60%
Last dividend (FY24) $0.64
Revenue growth (TTM) Revenue growth 14.81%
Revenue (TTM) Revenue $213.03m
EBIT (operating result TTM) EBIT $49.58m
Free Cash Flow (TTM) Free Cash Flow $33.49m
Cash position $123.89m
EPS (TTM) EPS $1.82
P/E forward 55.20
P/S forward 10.94
EV/Sales forward 10.46
Short interest 4.65%
Show more

Is LeMaitre Vascular, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

LeMaitre Vascular, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a LeMaitre Vascular, Inc. forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a LeMaitre Vascular, Inc. forecast:

Buy
70%
Hold
30%

Financial data from LeMaitre Vascular, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
213 213
15% 15%
100%
- Direct Costs 73 73
2% 2%
34%
140 140
23% 23%
66%
- Selling and Administrative Expenses 64 64
19% 19%
30%
- Research and Development Expense 16 16
1% 1%
8%
59 59
36% 36%
28%
- Depreciation and Amortization 9.64 9.64
3% 3%
5%
EBIT (Operating Income) EBIT 50 50
45% 45%
23%
Net Profit 41 41
52% 52%
19%

In millions USD.

Don't miss a Thing! We will send you all news about LeMaitre Vascular, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LeMaitre Vascular, Inc. Stock News

Neutral
GlobeNewsWire
about 14 hours ago
BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December.
Positive
Seeking Alpha
23 days ago
LeMaitre continues to expand in the peripheral vascular disease market, with recent revenue gains driven by premium pricing and international growth. Its strong dividend growth of 14.3% this year and double-digit CAGR over the past five years are particularly appealing. With a high-margin, low-competition niche and accelerating geographic expansion, LeMaitre remains well-positioned for sustaine...
Neutral
GlobeNewsWire
25 days ago
BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
More LeMaitre Vascular, Inc. News

Company Profile

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Head office United States
CEO George LeMaitre
Employees 630
Founded 1983
Website www.lemaitre.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today